The African Rare Disease Research Center (ARRC), in collaboration with Rotaract Club Kampala Mahaba (in formation) and partners, will commemorate World Rare Disease Day 2026 through a solidarity walk aimed at raising awareness for people living with rare diseases.
This event stands in solidarity with over 300 million people worldwide affected by rare diseases and highlights the importance of research, inclusion, and collective action.
Date: Saturday, 28 February 2026 Time: 07:00 – 09:00 AM Venue: National Theatre Grounds, Kampala
Stakeholders, partners, and members of the public are invited to join this meaningful cause as we advocate for awareness, support, and improved outcomes for individuals living with rare diseases.
📅 January 29, 2025
📍 Makerere University Biomedical Research Center (MakBRC)
MakBRC, in collaboration with the University of Florence, Italy, has officially launched the ALL-IN-ONE AMR Project. This initiative aims to combat antimicrobial resistance (AMR) and will focus on implementation in the Karamoja region, Uganda.
About the Project
The ALL-IN-ONE AMR Project is a multidisciplinary effort designed to address the growing challenge of AMR through innovative strategies and community-focused interventions. By leveraging the expertise of local and international researchers, the project seeks to provide sustainable solutions tailored to low-resource settings.
Kick-Off Meeting Highlights
The kick-off meeting brought together key stakeholders from Uganda and Italy, including researchers, project leaders, and community representatives. Discussions centered on:
Establishing project goals and objectives.
Strengthening collaboration between Makerere University and the University of Florence.
Planning research activities to address AMR in Karamoja.
Next Steps
With the groundwork laid during the kick-off meeting, the project team will now focus on field implementation and community engagement to ensure impactful outcomes.
MakBRC remains committed to contributing to global health research and addressing critical health challenges like AMR.
📷 Pictured: Participants of the kick-off meeting at the MakBRC Green House.
The Science, Technology and Innovation Secretariat at Office of the President and Scientists from Cuba visits the Biomarker Discovery lab at MakBRC
On 6th/Oct/2024 MakBRC hosted a team of scientists from STI-OP and Cuba at the Biomarker Discovery lab, located at Kasangati. The guests were welcomed by Dr. Ivan Mwebaza, the Head of Research and Innovations at MakBRC who emphasized the importance of this collaboration towards research, training, R&D, and skills transfer between Uganda and Cuba.
The guests, led by Dr. David Seruka and Ms Leah Nabirye from STI-OP. Scientists from Empresa de Servicios Ingenieros Especializados, Cuba (ESINES) were led by Dr. Figueroa Fernandez; Business and Development Director, Dr.Portuondo Vazquez; Deputy Director, and Dr. Sardina Fagundo; the Chief Architect & Project Manager.
The team also included Dr. Leyva Hernandez who is the Commercial & Business Director at Biocubafarma Group of Company. Dr. Palenzuela Diaz represented Immuneesayo Centre in Havana. The Ugandan embassy in Havana was represented by Dr. Komakech Paul who is an administrative assistant and also a Medical Intern at Medical University of Havana.
The purpose of this visit was to identify facilities and capital investments that can foster synergies and collaborative Research and Development (R&D) between MakBRC, STI-OP, and Cuban institutions. The Biomarker Discovery lab is one of such facilities since it is a place where basic and translational analysis of target biological markers can be performed, and prototypes validated before they progress to commercial production. Currently the lab is equipped with a high-performance liquid chromatograph-triple quadrupole mass spectrometer (LC/MS/MS) with mass range of m/z 2 to 2000.
HPLC Mass spectrometry in the Biomarker Discovery lab
The guests commended MakBRC for its commitment to developing capacity and championing innovations that reduce and mitigate disease burden in Uganda and beyond. They reiterated the importance of such high-tech research labs in preventing, detecting and responding to healthcare challenges and biologic threats.
The guests also visited the renovated and remodeled space where the HIV drug resistance and reservoir labs are to be established. Dr. Mwebaza informed the guests about the need for an HIV drug resistance testing facility as it ensures patients are given medications that are pharmacologically effective against the strain of HIV they have.
HPLC Mass spectrometry in the Biomarker Discovery lab
Such lab is crucial for mitigating the spread of antimicrobial resistance, and it is one step towards personalized HIV treatment in Uganda. He also informed the guests that by establishing facilities that conducts research on HIV reservoirs, MakBRC is positioning Ugandan Scientists to be part of the quest for the HIV cure.
Dr. Peter Kim, MD , Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID)
On the 18th June 2024, Makerere University Biomedical Research Center (MakBRC) was honored to host a distinguished guest Dr. Peter Kim, MD who is the Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID). His visit provided a unique opportunity for the research community of the College of Health Sciences-Makerere University to engage with one of the leading experts in the field of HIV/AIDS research. In lead with the Managing Director and Head of Research and Innovations MakBRC, Professor Moses Joloba and Dr. Ivan Mwebaza respectively, together with other scientists and researchers, Dr. Peter Kim was given a tour around MakBRC and the College of Health Sciences. Among the so many facilities he visited were the Genomics, Molecular and Immunology Laboratories and the IBRH3AU Biorespository. Dr. Peter Kim was over joyed to see the so much infectious disease research being undertaken and the available resources to support the same. To close off the visit, Dr. Peter Kim gave a presentation; sharing valuable insights into the latest advancements in therapeutic research, emphasizing groundbreaking approaches and ongoing efforts to combat infectious diseases globally. The presentation was very interactive and interesting as it saw so many vibrant committed young scientists engaging with the Director Therapeutics Research Program at the Division of AIDS, NIAID.
We as MakBRC commit to fostering collaborations with esteemed institutions like NIAID to enhance our understanding of infectious diseases and accelerate progress towards effective treatments. We extend our heartfelt thanks to Dr. Peter Kim, MD, Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) for his visit and enlightening presentation and looking forward to future collaborations that will further enrich our research endeavors.
Lab tour by Jamine
The Head Research and Innovations MakBRC, Dr. Ivan Mwebaza engaging Dr. Peter Kim
The Director NIAD visiting some of the laboratories.
The Director giving an insightful and interactive presentation to senior and young scientists at the College of Health Sciences, Makerere University.
Dr. Peter Kim, together with the Managing Director MakBRC Professor Moses Joloba
A brief discussion with the Dean School of Biomedical Sciences, Dr. David Kateete.
Dr. Peter Kim, MD , Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID)
On the 18th June 2024, Makerere University Biomedical Research Center (MakBRC) was honored to host a distinguished guest Dr. Peter Kim, MD who is the Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID). His visit provided a unique opportunity for the research community of the College of Health Sciences-Makerere University to engage with one of the leading experts in the field of HIV/AIDS research. In lead with the Managing Director and Head of Research and Innovations MakBRC, Professor Moses Joloba and Dr. Ivan Mwebaza respectively, together with other scientists and researchers, Dr. Peter Kim was given a tour around MakBRC and the College of Health Sciences. Among the so many facilities he visited were the Genomics, Molecular and Immunology Laboratories and the IBRH3AU Biorespository. Dr. Peter Kim was over joyed to see the so much infectious disease research being undertaken and the available resources to support the same. To close off the visit, Dr. Peter Kim gave a presentation; sharing valuable insights into the latest advancements in therapeutic research, emphasizing groundbreaking approaches and ongoing efforts to combat infectious diseases globally. The presentation was very interactive and interesting as it saw so many vibrant committed young scientists engaging with the Director Therapeutics Research Program at the Division of AIDS, NIAID.
We as MakBRC commit to fostering collaborations with esteemed institutions like NIAID to enhance our understanding of infectious diseases and accelerate progress towards effective treatments. We extend our heartfelt thanks to Dr. Peter Kim, MD, Director of the Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) for his visit and enlightening presentation and looking forward to future collaborations that will further enrich our research endeavors.
Lab tour by Jamine
The Head Research and Innovations MakBRC, Dr. Ivan Mwebaza engaging Dr. Peter Kim
The Director NIAD visiting some of the laboratories.
The Director giving an insightful and interactive presentation to senior and young scientists at the College of Health Sciences, Makerere University.
Dr. Peter Kim, together with the Managing Director MakBRC Professor Moses Joloba
A brief discussion with the Dean School of Biomedical Sciences, Dr. David Kateete.
